Cite
Desmopressin Acetate Before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Renal Failure -- Is it Really Beneficial?
MLA
Jose, Leena, et al. “Desmopressin Acetate Before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Renal Failure -- Is It Really Beneficial?” Indian Journal of Nephrology, vol. 32, no. 5, Sept. 2022, pp. 430–34. EBSCOhost, https://doi.org/10.4103/ijn.IJN_553_20.
APA
Jose, L., Kaul, A., Bhadauria, D., Kushwaha, R., Nandan, R., Lal, H., Prasad, N., Behera, M. R., & Patel, M. R. (2022). Desmopressin Acetate Before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Renal Failure -- Is it Really Beneficial? Indian Journal of Nephrology, 32(5), 430–434. https://doi.org/10.4103/ijn.IJN_553_20
Chicago
Jose, Leena, Anupma Kaul, Dharmendra Bhadauria, Ravi Kushwaha, Raghu Nandan, Hira Lal, Narayan Prasad, Manas Ranjan Behera, and Manas Ranjan Patel. 2022. “Desmopressin Acetate Before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Renal Failure -- Is It Really Beneficial?” Indian Journal of Nephrology 32 (5): 430–34. doi:10.4103/ijn.IJN_553_20.